Seek Returns logo

ASND vs. MTD: A Head-to-Head Stock Comparison

Updated

Here’s a clear look at ASND and MTD, comparing key factors like performance, valuation metrics, dividends, and financial strength. It’s built for investors or anyone curious to see how these two stocks match up.

Company Overview

MTD stands out with 23.55 billion USD in market value—about 2.47× ASND’s market cap of 9.55 billion USD.

MTD carries a higher beta at 1.40, indicating it’s more sensitive to market moves, while ASND remains steadier at 0.40.

ASND trades as an ADR, giving U.S. investors a simple on-ramp to its foreign shares, while MTD remains a standard domestic listing.

SymbolASNDMTD
Company NameAscendis Pharma A/SMettler-Toledo International Inc.
CountryDKUS
SectorHealthcareHealthcare
IndustryBiotechnologyMedical - Diagnostics & Research
CEOMr. Jan Moller MikkelsenMr. Patrick K. Kaltenbach
Price158.1 USD1,133.26 USD
Market Cap9.55 billion USD23.55 billion USD
Beta0.401.40
ExchangeNASDAQNYSE
IPO DateJanuary 28, 2015November 14, 1997
ADRYesNo

Performance Comparison

This chart compares the performance of ASND and MTD over the past year by tracking the growth of an initial $10,000 investment in each (starting one year ago).

Hover over the lines to see the investment’s value and total return (%) at specific dates.

Data is adjusted for dividends and splits.

Valuation Metrics Comparison

The section examines key financial ratios to assess the valuation of ASND and MTD based on earnings, cash flow, sales, and book value. Pay attention to the following notable points where extreme values stand out.

  • ASND posts a negative P/E of -24.55, reflecting last year’s net loss, while MTD at 27.85 signals healthy earnings.
  • ASND posts a negative forward PEG of -2.23, hinting at anticipated earnings decline, whereas MTD at 2.71 has projections for stable or growing earnings.
  • ASND has a negative P/B ratio of -44.19, indicating its liabilities exceed assets (negative equity). MTD, with a P/B of 7.31, maintains positive shareholder equity.
  • ASND has a negative Price-to-Free Cash Flow ratio of -27.43, signaling it consumed more cash than it produced over the last year—an important liquidity warning. In contrast, MTD (P/FCF 27.10) indicates positive free cash flow generation.
SymbolASNDMTD
Price-to-Earnings Ratio (P/E, TTM)-24.5527.85
Forward PEG Ratio (TTM)-2.232.71
Price-to-Sales Ratio (P/S, TTM)22.886.15
Price-to-Book Ratio (P/B, TTM)-44.197.31
Price-to-Free Cash Flow Ratio (P/FCF, TTM)-27.4327.10
EV-to-EBITDA (TTM)-35.7421.22
EV-to-Sales (TTM)23.786.67
EV-to-Free Cash Flow (TTM)-28.5029.41

Dividend Comparison

Neither ASND nor MTD currently pays a dividend yield; this often indicates they are reinvesting earnings for growth, prioritizing long-term expansion over immediate cash returns to shareholders.

SymbolASNDMTD
Dividend Yield (TTM)0.00%0.00%

Financial Strength Metrics Comparison

This section dives into the financial resilience of ASND and MTD, spotlighting key metrics like liquidity, leverage, and debt coverage. Check out the standout observations below where notable differences or extremes pop up.

  • Both ASND (quick ratio 0.71) and MTD (quick ratio 0.70) fall below 0.8, meaning their most liquid assets—excluding inventory—aren’t enough to meet short-term obligations. This could force them to rely on receivables, inventory turn, or external financing.
  • ASND has negative equity (debt-to-equity ratio -4.46), an unusual warning sign, while MTD at 0.64 maintains a conventional debt-to-equity balance.
  • With negative EBIT (-3.72), ASND cannot cover its interest payments. MTD, with an interest coverage of 16.23, meets its interest obligations.
SymbolASNDMTD
Current Ratio (TTM)1.041.01
Quick Ratio (TTM)0.710.70
Debt-to-Equity Ratio (TTM)-4.460.64
Debt-to-Assets Ratio (TTM)0.800.64
Interest Coverage Ratio (TTM)-3.7216.23